Former FDA Commissioner Dr. David Kessler has just released an important new book on diet and wieght loss. He spoke to Forbes ...

GLP-1 drugs like Wegovy and Ozempic are designed to treat type 2 diabetes, but are widely known for their effect on weight ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

Novo Nordisk NVO shares have gained 13.9% in the past month. Several factors related to the company’s pipeline, regulatory ...

Patients taking a GLP-1 for diabetes have a lower risk for AF at 3 years than those on other medications, report ...

Real-time index price for TSX Industrials Capped Index (TTIN), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Trials have confirmed the efficacy of GLP-1 RAs in achieving clinically sustained weight loss in people with obesity without diabetes.

A low-FODMAP (fermentable oligosaccharides, disaccharides, monosaccharides, polyols) diet can improve patients' irritable ...

A new research paper shows that, in some ways, U.S. prescription drug spending is not necessarily all that high.

While natural approaches to raising GLP-1 are not as potent as medications, they provide a drug-free approach to weight loss ...

Announced preclinical data demonstrating the bioequivalence of RT-114, a bispecific GLP-1/GLP-2 receptor agonist (PG-102), delivered orally via the RaniPill® capsule, to subcutaneous administration ...

Researchers reviewed the clinical characteristics of patients taking GLP-1 receptor agonists who develop NAION.